/Investors

Alychlo — Full Portfolio

11 tracked investments · listed companies and verified rows first

Itinerisitineris.netin𝕏✓ verified

Itineris develops utility software solutions that help water and energy companies optimize operations, manage energy and water consumption, and support environmental goals.

AI & Machine LearningEnergyEnterprise SoftwareGovTechSaaSNot stated

Edgard Vermeersch(CEO & Founder)in

Co-investorsSmartFinGimvPMV

Alychlo Real Estatealychlorealestate.com

Alychlo is a real estate company that develops residential investment projects in Durbuy, Belgium, offering properties designed for rest, relaxation, and community connection.

PropTechDurbuy, BE

BoardMarc Coucke(Founder, Alychlo)

Animalcare Groupanimalcare.co.ukin

Animal healthcare company specialising in the development and commercialisation of products for companion animals, equine and production animals; holds around 150 animal health pharma brands.

Co-investorsCharterhouse Capital Partners

Banqup Groupbanqup.comin

Banqup is an international fintech company offering an all-in-one SaaS platform for e-invoicing, e-payments, e-reporting, and e-trust solutions with built-in compliance, serving businesses, accountants, and financial institutions.

Enterprise SoftwareFintechSaaS

Hans Leybaert

Co-investorsFrancisco Partners

Greenyardgreenyard.groupin

Greenyard is a global supplier of fresh, frozen and prepared produce including fruits, vegetables, flowers and plants, serving customers and suppliers with distribution and processing solutions.

AgTechCircular EconomyConsumerFoodTech

Co-investorsAgri Investment Fund

miDiagnosticsmidiagnostics.cominDec 2024

miDiagnostics develops a portfolio of molecular diagnostic tests designed for rapid and accurate results to support healthcare professionals in clinical diagnosis and patient care.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLeuven, BE

Katleen Verleysen(Chief Executive Officer)in

Co-investorsPamica NVPMV

Sophia Geneticssophiagenetics.comin𝕏Jan 2019 · $77M

SOPHiA GENETICS develops the SOPHiA DDM data analytics platform for genomic and multimodal data analysis, offering solutions used in oncology research and in vitro diagnostics.

AI & Machine LearningBiotechDigital HealthMedical Devices

Co-investors360 CapitalaMoonBalderton CapitalCompoundHitachi VenturesACE & Company+2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ArenalBeyond MarsComateThier des Béguines

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.